MSSP1 Antibody

What is MSSP1 and what are its alternative nomenclatures in scientific literature?

MSSP1 is more commonly referred to in current literature as RBMS1 (RNA binding motif, single-stranded-interacting protein 1). Other alternative names include Single-stranded DNA-binding protein MSSP-1, Suppressor of CDC2 with RNA-binding motif 2 (SCR2), C2orf12, and cervical cancer oncogene 4 (HCC 4). The protein is characterized by ribonucleoprotein consensus sequences containing conserved motifs (RNP1 and RNP2) required for DNA binding .

What are the primary cellular functions of MSSP1/RBMS1?

MSSP1/RBMS1 is a single-stranded DNA binding protein that interacts with the region upstream of the MYC gene, binding specifically to the DNA sequence motif 5'-[AT]CT[AT][AT]T-3'. Research has implicated this protein in diverse cellular processes including:

• DNA replication

• Gene transcription regulation

• Cell cycle progression

• Apoptosis induction

Notably, functional analyses have demonstrated that MSSP1 acts as a transcriptional regulator, specifically functioning as a suppressor for the alpha-smooth muscle actin gene promoter .

What is the cellular localization of MSSP1/RBMS1?

MSSP1/RBMS1 primarily localizes to the nucleus, consistent with its role in DNA binding and transcriptional regulation . This nuclear localization is critical for its function in gene regulation and DNA replication processes.

What types of MSSP1/RBMS1 antibodies are available for research applications?

Two main types of MSSP1/RBMS1 antibodies are available:

• Polyclonal antibodies:

  • Rabbit-derived polyclonal antibodies that recognize multiple epitopes

  • Suitable for various applications including IHC, WB, IF, IP and ELISA

  • Examples include those described in search results

• Monoclonal antibodies:

  • More specific to single epitopes

  • Provide more consistent results between experiments

  • May have narrower application ranges

Each antibody type has specific advantages depending on the experimental context.

How should I select the appropriate MSSP1/RBMS1 antibody for my experiment?

Selection criteria should include:

For optimal results, select antibodies specifically validated for your application of interest and experimental model.

What are the recommended dilution ranges for MSSP1/RBMS1 antibodies in different applications?

Optimal dilutions vary by application and specific antibody:

These ranges should be considered starting points, and optimization for specific experimental conditions is strongly recommended.

What is the optimal storage protocol for maintaining MSSP1/RBMS1 antibody activity?

To maintain antibody integrity:

• Store at -20°C in manufacturer-supplied buffer (typically PBS with stabilizers)

• Include 50% glycerol to prevent freeze-thaw damage

• Add preservatives (0.02-0.1% sodium azide or proclin300)

• Avoid repeated freeze-thaw cycles by preparing working aliquots

• Follow manufacturer's guidance on shelf-life (typically 12 months)

Improper storage significantly impacts antibody performance and experimental reproducibility.

Can MSSP1/RBMS1 antibodies be recycled for multiple experiments?

While antibody recycling is generally not recommended due to potential performance degradation, limited recycling may be possible with proper precautions:

• High-titer antibodies may permit up to three reuse cycles

• After incubation, collect unused antibody solution in a centrifuge tube

• Store recycled antibody at 4°C

• Use within approximately one week

• Expect potential reduction in binding efficiency with each reuse

Performance of recycled antibodies cannot be guaranteed and should be validated for critical experiments.

What controls are essential when using MSSP1/RBMS1 antibodies?

Rigorous experimental design requires these controls:

• Positive controls: Samples known to express MSSP1/RBMS1 (e.g., specific cell lines)

• Negative controls:

  • Samples lacking MSSP1/RBMS1 expression

  • Isotype-matched control antibodies (e.g., normal rabbit IgG for rabbit polyclonals)

• Technical controls:

  • Secondary antibody-only control (omitting primary antibody)

  • Blocking peptide competition (if available)

  • RBMS1 knockdown/knockout samples

These controls help distinguish specific from non-specific signals and validate antibody performance.

How can I optimize Western blot protocols for MSSP1/RBMS1 detection?

For optimal Western blot results:

• Sample preparation:

  • Use nuclear extracts (given nuclear localization)

  • Include protease inhibitors to prevent degradation

  • Denature samples completely (MSSP1 is ~45 kDa)

• Blotting conditions:

  • Start with 1:500-1:2000 antibody dilution and optimize

  • Incubate primary antibody overnight at 4°C

  • Use PVDF membranes for better protein retention

  • Include 5% BSA or milk in blocking buffer

• Detection system:

  • Enhanced chemiluminescence (ECL) systems provide sensitive detection

  • Consider fluorescent secondary antibodies for quantitative analysis

What is known about MSSP1/RBMS1's role in transcriptional regulation?

MSSP1/RBMS1 functions as a transcriptional regulator through several mechanisms:

• It binds to a specific negative regulatory element (TATCTTA sequence) in the alpha-smooth muscle actin gene promoter region

• Overexpression of MSSP1 in cultured smooth muscle cells suppresses promoter activity

• The protein shows preferential binding to single-stranded DNA over double-stranded DNA

• Its regulatory function suggests involvement in smooth muscle phenotype modulation

This transcriptional suppression activity represents a novel function of MSSP1/RBMS1 that may be relevant to various physiological and pathological processes.

How does MSSP1/RBMS1 relate to c-myc and what are the implications for cancer research?

MSSP1 was originally identified through its interaction with the c-myc gene, a proto-oncogene critical in cell proliferation and cancer development:

• MSSP1 binds to the region upstream of the MYC gene

• It shows specific binding to the DNA sequence motif 5'-[AT]CT[AT][AT]T-3'

• This interaction may influence c-myc expression and downstream cellular processes

• MSSP1/RBMS1 has been referred to as "Cervical cancer oncogene 4" (HCC 4)

These characteristics make MSSP1/RBMS1 antibodies valuable tools in cancer research, potentially illuminating regulatory mechanisms in oncogenesis.

What are common issues with MSSP1/RBMS1 immunohistochemistry and how can they be resolved?

For immunohistochemical applications:

For verified samples in IHC applications, human colon cancer and ovarian cancer tissues have been successfully used with RBMS1 antibodies .

How can I validate the specificity of my MSSP1/RBMS1 antibody?

Multiple validation approaches should be employed:

• Western blot analysis: Confirm detection of a band at approximately 45 kDa in nuclear extracts

• Genetic validation:

  • siRNA/shRNA knockdown of RBMS1 should reduce antibody signal

  • Overexpression of RBMS1 should increase antibody signal

• Peptide competition: Pre-incubation with the immunizing peptide should abolish specific signal

• Cross-application validation: Confirm consistent results across multiple applications (WB, IF, IHC)

Thorough validation ensures experimental reliability and reproducibility.

How can I determine if my MSSP1/RBMS1 antibody detects all protein isoforms?

MSSP1/RBMS1 exists in several isoforms resulting from alternative splicing . To determine isoform detection:

• Review literature and database information on known isoforms

• Check epitope location relative to alternative splicing regions

• Run Western blots on samples known to express different isoforms

• Compare molecular weights of detected bands with predicted isoform sizes

• Consider using antibodies targeting different epitopes to capture all isoforms

Understanding isoform detection is critical for accurate interpretation of experimental results.

How can MSSP1/RBMS1 antibodies be used to study apoptotic mechanisms?

MSSP1 has been implicated in apoptotic processes, making antibodies against this protein valuable for studying programmed cell death:

• Research by Iida et al. demonstrated that MSSP proteins can induce apoptosis in HeLa cells

• Antibodies can be used to:

  • Track MSSP1/RBMS1 expression levels during apoptosis induction

  • Examine subcellular localization changes during apoptotic processes

  • Identify protein interaction partners in apoptotic pathways

  • Assess post-translational modifications that may regulate apoptotic function

Such studies may provide insights into cancer biology and cellular response to stress conditions.

What techniques can be used to study MSSP1/RBMS1 binding to nucleic acids?

To investigate MSSP1/RBMS1's DNA/RNA binding properties:

• Chromatin immunoprecipitation (ChIP): Using MSSP1/RBMS1 antibodies to identify genomic binding sites in vivo

• Electrophoretic mobility shift assay (EMSA): Detecting protein-DNA interactions with specific sequence probes

• RNA immunoprecipitation (RIP): Identifying RNA molecules bound by MSSP1/RBMS1

• Proximity ligation assay (PLA): Visualizing MSSP1/RBMS1 interactions with nucleic acids in situ

Research has shown MSSP1 binds the TATCTTA sequence in the alpha-SM actin promoter region, with stronger affinity for single-stranded versus double-stranded DNA .

How might MSSP1/RBMS1 antibodies contribute to understanding smooth muscle cell phenotype regulation?

MSSP1/RBMS1 has been shown to suppress alpha-smooth muscle actin gene expression , suggesting potential roles in:

• Vascular smooth muscle cell phenotypic switching

• Airway remodeling in respiratory diseases

• Gastrointestinal smooth muscle development and pathology

• Cardiac smooth muscle regulation

Antibodies against MSSP1/RBMS1 can facilitate:

• Tracking expression levels during phenotypic modulation

• Identifying cell-specific regulatory mechanisms

• Examining transcriptional complex formation at smooth muscle-specific promoters

• Investigating potential therapeutic targets for smooth muscle disorders

This research direction connects MSSP1/RBMS1 function to broader physiological and pathological processes.